VC-backed Maverick Therapeutics recruits Scibetta as CEO
Brisbane, California-based Maverick Therapeutics Inc., an immuno-oncology company, has appointed James S. Scibetta as CEO and a member of its board of directors. Previously, Scibetta worked at Pacira Pharmaceuticals where he served as the company’s president of global R&D, manufacturing and capacity expansion activities, as well as commercial and medical support activities. Maverick Therapeutics is backed by MPM Capital.
11 August 2017•3 mins read
